Extensive financial links between the leaders of US respiratory specialist associations and the pharmaceutical and medical device industries have raised concerns over independence and integrity. More than A$5.3 million (US$3.6m) in industry payments flowed to leaders of the American Thoracic Society (ATS) over a five year period according to figures published in BMJ. But respiratory ...
Respiratory specialist leaders criticised for financial entanglements with industry
By Michael Woodhead
2 Jun 2020